CANADIAN JOURNAL OF CARDIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2024-10-19 1203a508m05暂无昵称来自北京

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：标志物;心外科
经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～

第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。

修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。

小修修回后4天接收。祝各位都投稿顺利～

31 0

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2024-06-14 ms8000001052932104 来自江苏省

20240514投稿 20240614仍然在under review…

55 0

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2019-11-16 努力的科研小白

接收综述吗？需要版面费吗？

224 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2023-01-28 ms6000001445187607 来自陕西省

这个期刊一作可以有几位？可以共一吗？

90 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2021-12-28 小动量

讨论中我和之前发表文章结果不一致怎么处理？

94 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2021-12-28 Mia

讨论中一般可以讨论什么？

91 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2021-12-22 ms5000000444908658

朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？

102 0

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2021-07-27 cacojin

审稿速度:1.0 | 投稿命中率:25.0
经验分享：编辑非常效率，几天拒稿

133 0

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2020-01-02 misssheng

这个杂志只收临床的文章吗？还是偏重临床？

242 0

[GetPortalCommentsPageByObjectIdResponse(id=2231677, encodeId=8c5622316e774, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：标志物;心外科 经验分享：CJC作为加拿大心血管协会的官方刊物，个人感觉还是很值得投的～～ 第一版投出后刚好1个月返回意见，major revision。两位审稿人，都提了不少意见，各个方面都有，包括伦理、统计、定义、方法等，都是切中要害的好问题，不是故意刁难那种。编辑部给了3个月的修改时间，花了不少功夫，还剩两周的时候修回。 修回后还是1个月返回意见，这次是minor revision，又多了一位审稿人。虽说是小修，但问题也都需要补充分析、查阅文献才能较好回答。又花了两周回复意见。 小修修回后4天接收。祝各位都投稿顺利～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a3e2164041, createdName=1203a508m05暂无昵称, createdTime=Sat Oct 19 07:15:29 CST 2024, time=2024-10-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2209895, encodeId=90992209895bb, content=20240514投稿 20240614仍然在under review…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Fri Jun 14 14:06:11 CST 2024, time=2024-06-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=579948, encodeId=2e9c5e99488c, content=接收综述吗？需要版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=224, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ba5226495, createdName=努力的科研小白, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111808, encodeId=a5db21118081d, content=这个期刊一作可以有几位？可以共一吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58178506589, createdName=ms6000001445187607, createdTime=Sat Jan 28 09:55:37 CST 2023, time=2023-01-28, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=1088324, encodeId=c9e5108832411, content=讨论中我和之前发表文章结果不一致怎么处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088323, encodeId=ce7710883231c, content=讨论中一般可以讨论什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083209, encodeId=dc711083209ff, content=朋友们，有人知道这个杂志是不是只有一个第一作者，不能共一啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85125534559, createdName=ms5000000444908658, createdTime=Wed Dec 22 20:58:32 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002932, encodeId=7a6a1002932b5, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：编辑非常效率，几天拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=7cdb5533537, createdName=cacojin, createdTime=Tue Jul 27 10:03:30 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582575, encodeId=6f5c5825e503, content=这个杂志只收临床的文章吗？还是偏重临床？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=0aad95230, createdName=misssheng, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=852944, encodeId=6feb8529444d, content=一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Aug 02 09:59:04 CST 2019, time=2019-08-02, status=1, ipAttribution=)]

2019-08-02 ms9285292773773234

一次大修一次小修，每轮审稿1个月左右，很细致，提出很多被忽视的问题

208 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务